StockData
OKYO Pharma Ltd logo

OKYO Pharma Ltd (OKYO) stock

OKYONasdaqBiological Products, (No Diagnostic Substances)
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30
$1.11−0.06 (-5.13%)

Close on Nov 17, 2026Market cap $58.25MP/E –Yield –

OKYO Pharma operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2026 it was -$5.94M. The highest annual figure on record is -$1.20M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$5.94M–
FY2025Mar 31, 2025-$1.81M–
FY2024Mar 31, 2024-$9.49M–
FY2023Mar 31, 2023-$7.70M–
FY2022Mar 31, 2022-$5.47M–
FY2021Mar 31, 2021-$1.60M–
FY2020Mar 31, 2020-$1.20M–

More OKYO Pharma figures

See a number that looks wrong?